Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |